发明名称 Super-antigens derived from the SARS coronavirus E2 spike protein
摘要 <p>The present invention relates to a super-antigen fusion protein, comprising: a peptide fragment derived from SARS E2 spike protein; and a translocating peptide fragment for transporting a protein into a cell and translocating the protein in cytosol; wherein, the SARS E2 spike protein fragments locate between the amino acid position 692 and 1050 of the viral protein. The present invention further relates to DNA sequences encoding the SARS E2 spike protein fragments and fusion protein thereof; wherein the DNA sequences are able to express the proteins in an E. Coli expression system. The preferred translocating peptide is obtained from Pseudomonas exotoxin.</p>
申请公布号 EP1749833(A1) 申请公布日期 2007.02.07
申请号 EP20050254884 申请日期 2005.08.05
申请人 HEALTHBANKS BIOTECH CO., LTD. 发明人 CHANG, HSIU-KANG;LIAO, CHAO-WE;CHENG, WEN-FANG
分类号 C07K14/165;A61K38/16;C07H21/00;C07K19/00 主分类号 C07K14/165
代理机构 代理人
主权项
地址